Using Bayesian Optimization to Accelerate Virtual Screening for the
  Discovery of Therapeutics Appropriate for Repurposing for COVID-19
  The novel Wuhan coronavirus known as SARS-CoV-2 has brought almost
unprecedented effects for a non-wartime setting, hitting social, economic and
health systems hard.~ Being able to bring to bear pharmaceutical interventions
to counteract its effects will represent a major turning point in the fight to
turn the tides in this ongoing battle.~ Recently, the World's most powerful
supercomputer, SUMMIT, was used to identify existing small molecule
pharmaceuticals which may have the desired activity against SARS-CoV-2 through
a high throughput virtual screening approach. In this communication, we
demonstrate how the use of Bayesian optimization can provide a valuable service
for the prioritisation of these calculations, leading to the accelerated
identification of high-performing candidates, and thus expanding the scope of
the utility of HPC systems for time critical screening
